BIOMERICA INC Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
BIOMERICA INC (BMRA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$16.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-08-31
- BIOMERICA INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2026 was -$16.00K.
- BIOMERICA INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was -$75.00K.
- BIOMERICA INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was -$148.00K.
- BIOMERICA INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was -$17.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2026-05-31 | -$16.00K 10-K · filed 2026-08-31 | |
| 2025-05-31 | -$75.00K 10-K · filed 2026-08-31 | $75.00K 10-K · filed 2025-08-29 |
| 2024-05-31 | -$148.00K 10-K · filed 2025-08-29 | |
| 2023-05-31 | -$17.00K 10-K · filed 2024-08-28 | |
| 2022-05-31 | -$197.00K 10-K · filed 2023-08-25 | -$217.00K 10-K · filed 2022-08-29 |
| 2021-05-31 | -$88.00K 10-K · filed 2022-08-29 | $98.82K 10-K · filed 2021-08-27 |
| 2020-05-31 | $179.04K 10-K/A · filed 2021-10-14 | $21.52K 10-K · filed 2020-08-31 |
| 2019-05-31 | -$256.57K 10-K · filed 2020-08-31 | |
| 2018-05-31 | $78.80K 10-K · filed 2019-08-29 | |
| 2017-05-31 | $8.58K 10-K · filed 2018-08-29 | -$8.58K 10-K · filed 2017-08-29 |
| 2016-05-31 | -$3.60K 10-K · filed 2017-08-29 | $3.60K 10-K · filed 2016-08-29 |
| 2015-05-31 | -$1.00K 10-K · filed 2016-08-29 | $1.00K 10-K · filed 2015-08-31 |
| 2014-05-31 | $11.00K 10-K · filed 2015-08-31 | |
| 2013-05-31 | $7.51K 10-K · filed 2014-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |